SCHEMBL26404353

SCHEMBL26404353

c1ccc(-c2ccc3c(c2)oc2ccc(-c4c5ccccc5c(-c5ccccc5-c5ccccc5)c5ccccc45)cc23)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLA2G2A P14555 4/20 0.42
PLA2G4A P47712 4/20 0.42
MMP12 P39900 1/20 0.39
MMP13 P45452 1/20 0.39
PLA2G10 O15496 1/20 0.37
AHR P35869 2/20 0.37
KDM4E B2RXH2 2/20 0.37
MEN1 O00255 2/20 0.37
ALDH1A1 P00352 2/20 0.37
MAPT P10636 2/20 0.37
HPGD P15428 2/20 0.37
KMT2A Q03164 2/20 0.37
NPC1 O15118 2/20 0.37
RAB9A P51151 2/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
HSP90AA1 P07900 1/20 0.37
HSP90AB1 P08238 1/20 0.37
HCRTR1 O43613 1/20 0.35
PIM1 P11309 1/20 0.35
CSNK2A2 P19784 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27011631 1.00 PLA2G2A (0.42) PLA2G2APLA2G4AMMP12MMP13PLA2G10
SCHEMBL22987256 0.97 PLA2G2A (0.43) PLA2G2APLA2G4AMMP12MMP13PLA2G10
SCHEMBL25624664 0.94 PLA2G2A (0.45) PLA2G2APLA2G4AMMP12MMP13PLA2G10
SCHEMBL25624663 0.94 PLA2G2A (0.45) PLA2G2APLA2G4AMMP12MMP13PLA2G10
SCHEMBL27011627 0.94 MMP12 (0.40) PLA2G2APLA2G4AMMP12MMP13AHR
SCHEMBL22854976 0.94 PLA2G2A (0.46) PLA2G2APLA2G4APLA2G10KDM4EMEN1
SCHEMBL25102758 0.94 PLA2G2A (0.41) PLA2G2APLA2G4AMMP12MMP13PLA2G10
SCHEMBL22854993 0.93 PLA2G2A (0.44) PLA2G2APLA2G4AMMP12MMP13PLA2G10
SCHEMBL20109961 0.93 PLA2G2A (0.40) PLA2G2APLA2G4AMMP12MMP13PLA2G10
SCHEMBL24285561 0.93 AHR (0.44) PLA2G2APLA2G4AMMP12MMP13AHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024096410-A1 ORGANIC LIGHT-EMITTING DEVICE 주식회사 엘지화학 2024-05-10 WO disclosed
US-20240023436-A1 ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2024-01-18 US disclosed
US-20230320214-A1 ORGANIC LIGHT-EMITTING DEVICE INCLUDING ORGANIC COMPOUND LG CHEM, LTD. (KR) 2023-10-05 US disclosed
US-20230320214-A1 ORGANIC LIGHT-EMITTING DEVICE INCLUDING ORGANIC COMPOUND LG CHEM, LTD. (KR) 2023-10-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240023436-A1 ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE EED, EML4, ESR1 PLA2G2A 3402/4885PLA2G4A 4288/4885MMP12 4022/4885
US-20230320214-A1 ORGANIC LIGHT-EMITTING DEVICE INCLUDING ORGANIC COMPOUND CYP1A1, AOX1, CYP1B1 PLA2G2A 4379/4885PLA2G4A 4323/4885MMP12 4099/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.